✦ LIBER ✦

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical significance of serum autoantib

Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network

✍ Raj Vuppalanchi; Robert J. Gould; Laura A. Wilson; Aynur Unalp-Arida; Oscar W. C 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 194 KB

Quality of life in adults with nonalcoho

Quality of life in adults with nonalcoholic fatty liver disease: Baseline data from the nonalcoholic steatohepatitis clinical research network

✍ Kristin David; Kris V. Kowdley; Aynur Unalp; Fasiha Kanwal; Elizabeth M. Brunt; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 315 KB 👁 1 views

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the United States. The association between NAFLD and quality of life (QOL) remains unclear. These data are important to estimate the burden of illness in NAFLD. The aim was to report QOL scores of adults with NAFLD

Portal chronic inflammation in nonalcoho

Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): A histologic marker of advanced NAFLD—Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network

✍ Elizabeth M. Brunt; David E. Kleiner; Laura A. Wilson; Aynur Unalp; Cynthia E. B 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB 👁 2 views

Ethnicity and nonalcoholic fatty liver d

Ethnicity and nonalcoholic fatty liver disease

✍ Kiran Bambha; Patricia Belt; Maria Abraham; Laura A. Wilson; Mark Pabst; Linda F 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 825 KB

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disorder in the United States; however, few data are available about racial and ethnic variation. We investigated relationships between ethnicity, NAFLD severity, metabolic derangements, and sociodemographic characteristics in a well-

Endpoints and clinical trial design for

Endpoints and clinical trial design for nonalcoholic steatohepatitis

✍ Arun J. Sanyal; Elizabeth M. Brunt; David E. Kleiner; Kris V. Kowdley; Naga Chal 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 1 views

Nonalcoholic fatty liver disease is a common cause of chronic liver disease in the general population. Nonalcoholic steatohepatitis (NASH), the aggressive form of nonalcoholic fatty liver disease, is associated with an increased risk of liver-related mortality and cardiovascular disease. At present,

Increased fructose consumption is associ

Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease

✍ Manal F. Abdelmalek; Ayako Suzuki; Cynthia Guy; Aynur Unalp-Arida; Ryan Colvin; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 1 views

The rising incidence of obesity and diabetes coincides with a marked increase in fructose consumption. Fructose consumption is higher in individuals with nonalcoholic fatty liver disease (NAFLD) than in age-matched and body mass index (BMI)-matched controls. Because fructose elicits metabolic pertur

Nonalcoholic steatohepatitis clinical research network